Hardman Research

Hardman & Co

Futura Medical plc Maximising the return on MED2002

Futura Medical plc (LON:FUM) has advanced transdermal technology which can be incorporated into formulations of well characterised drugs to improve performance and extend their uses. MED2002 is a topical gel of